Wamble v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
Florida Southern District Court | |
Judge: | Robin L Rosenberg |
Referred: | Bruce E Reinhart |
Case #: | 9:20-cv-80268 |
Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
Cause | 28:1332 Diversity |
Case Filed: | Feb 24, 2020 |
Terminated: | Feb 27, 2020 |
Case in other court: | Kentucky Western, 5:20-cv-00011 |
Last checked: Saturday Aug 22, 2020 7:56 AM EDT |
Defendant
Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
Defendant
Chattem Inc.
|
|
Defendant
GlaxoSmithKline LLC
|
|
Defendant
Pfizer Inc
|
|
Defendant
Sanofi US Services Inc.
|
|
Plaintiff
Christopher Wamble
|
Represented By
|
Docket last updated: 11 hours ago |
Friday, June 10, 2022 | ||
16 | 16
order
Administrative Order
Mon 06/13 2:07 PM
ORDER DECONSOLIDATING CASES. This case is DECONSOLIDATED from MDL proceeding 20-MD-2924. Case remains closed. Signed by Judge Robin L. Rosenberg on 6/10/2022. See attached document for full details. (pes) |
|
15 | 15
notice
Notice of Voluntary Dismissal - aty
Fri 06/10 4:13 PM
NOTICE of Voluntary Dismissal Without Prejudice by Christopher Wamble (Muhlstock, Melanie) |
|
14 | 14
notice
Notice of Striking
Fri 06/10 4:10 PM
NOTICE of Striking13 Notice of Voluntary Dismissal filed by Christopher Wamble by Christopher Wamble (Muhlstock, Melanie) |
|
13 | 13
notice
Notice of Voluntary Dismissal - aty
Fri 06/10 3:42 PM
STRICKEN per DE# [14[, NOTICE of Voluntary Dismissal Without Prejudice by Christopher Wamble (Muhlstock, Melanie) Modified text on 6/10/2022 (jas) |
|
Friday, August 21, 2020 | ||
12 | 12
cmp
MDL Amended Complaint
Fri 08/21 3:30 PM
MDL AMENDED COMPLAINT Short Form Complaint against All Defendants, filed by Christopher Wamble.(Muhlstock, Melanie) |
|
Thursday, February 27, 2020 | ||
11 | 11
order
Administrative Order
Thu 02/27 4:11 PM
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 2/27/2020. See attached document for full details. (mc) |
|
Monday, February 24, 2020 | ||
10 | 10
order
Pretrial Order
Mon 02/24 1:42 PM
PRETRIAL ORDER #1: Setting Initial Conference. Signed by Judge Robin L. Rosenberg on 2/14/2020. See attached document for full details. (pes) |
|
9 | 9
order
Clerk's Notice of Judge Assignment and Optional Consent
Mon 02/24 1:05 PM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg and Magistrate Judge Bruce E. Reinhart. (pes) |
|
8 | 8
transfer
Case Transferred In - District Transfer - CV - NO FEE
Mon 02/24 1:02 PM
Case transferred in from Kentucky Western; Case Number 5:20-cv-00011. Electronic file including transfer order and docket sheet received. .(pes) |
|
Friday, February 21, 2020 | ||
7 | 7 CONDITIONAL TRANSFER ORDER No. CTO-1 from Southern Florida re MDL 2924. (KJA) | |
Monday, February 10, 2020 | ||
6 | 6 ATTORNEY NOTICE of Deficiency to Christopher C. Oxx re1 Complaint.Reason for Deficiency: motion to appear pro hac vice not filed. Failure to comply will be brought to the attention of the Court. Response due by 2/28/2020. (KJA) | |
5 | 5 ATTORNEY NOTICE of Deficiency to Harrison M. Biggs re1 Complaint.Reason for Deficiency: motion to appear pro hac vice not filed. Failure to comply will be brought to the attention of the Court. Response due by 2/28/2020. (KJA) | |
4 | 4 ATTORNEY NOTICE of Deficiency to Raymond C. Silverman re1 Complaint.Reason for Deficiency: motion to appear pro hac vice not filed. Failure to comply will be brought to the attention of the Court. Response due by 2/24/2020. (KJA) | |
Friday, January 24, 2020 | ||
3 | 3 Summons Issued as to Boehringer Ingelheim Pharmaceuticals, Inc., Chattem, Inc., GlaxoSmithKline LLC, Pfizer, Inc., and Sanofi US Services, Inc. Counsel for Plaintiff is responsible for printing and serving the attached issued summons(es). (MNM) | |
Thursday, January 23, 2020 | ||
2 | 2 Case Assignment (Random Selection): Case Assigned to Senior Judge Thomas B. Russell. (MNM) | |
1 | 1 COMPLAINT against Boehringer Ingelheim Pharmaceuticals, Inc., Chattem, Inc., GlaxoSmithKline LLC, Pfizer, Inc., and Sanofi US Services, Inc. Filing fee $400, receipt number 0644-3027011, filed by Christopher Wamble. (MNM) | |
Att: 1 Cover Sheet, | ||
Att: 2 Summons Tendered |